Allianz Asset Management
VTAE

Allianz Asset Management’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Allianz Asset Management’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,350,000
Closed -$28.2M – 2764
2016
Q3 		$28.2M Buy
+1,350,000
New +$15.5M 0.03% 773
2015
Q3 		– Sell
-91,231
Closed -$1.31M – 2496
2015
Q2 		$1.31M Buy
+91,231
New +$1.24M ﹤0.01% 1861

Allianz Asset Management's VTAE Position: Q4 2016 in Review

Allianz Asset Management sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 1,350,000 shares — an estimated $28.2M sold.

Allianz Asset Management first reported a position in VTAE in Q2 2015 and held it in 2 quarters. The position peaked at $28.2M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

  • Allianz Asset Management reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
  • Allianz Asset Management sold 1,350,000 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $28.2M.
  • Allianz Asset Management first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q2 2015 and held it in 2 quarters.
  • Allianz Asset Management's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $28.2M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Allianz Asset Management's 13F filing for Q4 2016, filed 13 Feb 2017.